Opioid Overdose Treatment: Walgreens To Stock FDA-Approved NARCAN Spray
Portfolio Pulse from Shivani Kumaresan
Walgreens Boots Alliance Inc (WBA) announced that over-the-counter NARCAN Nasal Spray will be available at its stores and online from September 5, following FDA approval. Emergent BioSolutions Inc (EBS), the maker of NARCAN, also announced that Naloxone 4 mg will be available nationwide from September. The spray can reverse the effects of opioids, including fentanyl.
August 30, 2023 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Emergent BioSolutions, the maker of NARCAN Nasal Spray, announced that Naloxone 4 mg will be available nationwide from September.
The announcement by Emergent BioSolutions about the availability of Naloxone 4 mg, a component of NARCAN Nasal Spray, could potentially increase the company's revenues. This could have a positive impact on the company's stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Walgreens will start selling NARCAN Nasal Spray, an FDA-approved opioid overdose treatment, in its stores and online from September 5.
The availability of NARCAN Nasal Spray in Walgreens stores could potentially increase the company's revenues as it is an FDA-approved treatment for opioid overdose. This could have a positive impact on the company's stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100